Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
Alessandra Bosch, Clinician Scientist at University of Zurich, shared a post on LinkedIn:
“Such an inspiring Saturday at the Von Willebrand Disease and Rare Bleeding Disorders Patient Day (SHG) in Bern a full day dedicated to von Willebrand disease and rare bleeding disorder patients, held in German and French with simultaneous translation.
It was great to share the stage with colleagues AlessandroCasini (HUG) on new treatments and therapies for rare bleeding disorders, and Sebastien L. (HUG, UCLouvain) on the role of physiotherapy and joint assessment in Von Willebrand disease, including a hands on ultrasound workshop.
I had the pleasure of presenting on bleeding symptoms in women and girls with bleeding disorders, and giving a workshop on heavy menstrual bleeding in adolescents young women.
Thank you to the Swiss Haemophilia Society for organizing such a valuable event for the bleeding disorders community.
And a big THANKS to the patients for your active participation!”
Stay updated with Hemostasis Today.
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination
-
Oct 23, 2026, 15:29José Antonio García Erce: Preoperative Anemia Emerges as a Modifiable Surgical Risk in New POWER Study
-
Oct 23, 2026, 15:13Reza Shojaei: Manufactured Red Blood Cells vs Blood Donation
-
Oct 23, 2026, 14:29Jean Jacques Kiladjian: International Scientific Exchange at IHCAMS in Tianjin
-
Oct 23, 2026, 14:11Aravind Palraj: The Prolonged aPTT Puzzle in SLE
-
Oct 23, 2026, 13:56Chokri Ben Lamine: The Evolving Treatment Landscape of Persistent and Chronic ITP